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Abstract
Aim. To study the main indices of lipid blood spectrum, which changes lead to DL formation, depending of body mass index 
(BMI) and concomitant pathology of biliary tract in patients with NASH and obesity. 
Materials and methods. There were examined 100 patients with NASH in combination with obesity and BT pathology, in 
which during sonographic or morphological study of bioptat of the liver were revealed the signs of hepatic steatosis. Among patients 
were 40 men and 60 women. The mean age of patients – (54,68±1,15) years old. The control group included 20 practically healthy 
persons (PHP). 
BMI was determined by Quetelet formula. Depending of the degree of BMI increase all patients with NASH and obesity 
were divided into three groups: 1 group – with BМI 25–29,9 kg/m2 – EBM; 2 group – with BMI 30–34,9 kg/m2 – obesity of I de-
gree; 3 group – with BMI 35–39,9 kg/m2 – obesity of ІІ degree. All examined patients had concomitant pathology from BT side. 
Depending on BT pathology all patients were also divided into 3 groups: NASH with chronic non-calculous cholecystitis (CNC); 
NASH with chronic calculous cholecystitis (CCC); NASH in patients after laparoscopic cholecystectomy (LCE) with concomitant 
postcholecystectomical syndrome (PCES). For characteristic of lipid exchange were determined the general cholesterol (GCS), gen-
eral lipids (GL), triglycerides (TG), lipoproteins of the low density (LDL), lipoproteins of the high density (HDL). DL phenotype was 
determined by D. S. Fredrickson classification with modern additions. 
Results. Analysis of lipid changes in patients with NASH demonstrated the reliable increase of GCS with parallel rise of TG, 
GL, LDL, fixed at increase of BMI relative to PHP (р<0,05, р<0,001) and to patients of other groups (р<0,05). Maximal values of 
GCS, TG, GL and also LDL were determined in 2 and 3 groups of observation at obesity of I and II degrees. There was registered the 
reliable decrease of HDL content in most patients of 3 group relative to the ones of 2 group, (р<0,01) and of 1 one. 
The level of GCS, TG, GL and LDL was almost equally increased in all groups of observation of NASH: with concomitant 
CNC, CCC and in patients with PCES relative to PSP, (р<0,001). HDL indices were equally decreased at concomitant CNC and CCC 
relative to the patients with PCES background with HDL level within physiological norm (р<0,001, рF=0,009). 
There are separated two main phenotypes of DL: IIa and IIb that were typical for patients with NASH and obesity with BT patholo-
gy. It was established, that IIb phenotype of dyslipidemia was most often observed in patients with BMI 30–34,9 kg/m2 and 35–39,9 kg/m2.
Discussion. There were determined the features of changes of lipid blood spectrum of in this category of patients that are 
manifested by variability of disorders from hypercholesterolemia and hypertriglyceridemia on the background of increase of GCS, 
TG, GL, LDL and decrease of HDL. The progression of lipid disorders in patients with NASH in combination with obesity and BT 
pathology depends on increase of BMI parameters. 
The concomitant pathology from BT side partially influenced the indices of lipid blood spectrum. Thus, the low level of HDL 
in patients with NASH in combination with obesity and concomitant CNC and CCC can be explained by the intense inflammatory 
processes in BT, attended with disorder of indices of lipid profile with decrease of HDL and increase of GCS, TG, GL, LDL. 
Conclusion. Progression of intensity of lipid disorders in patients with NASH in combination with obesity and BT pathology 
depends on increase of BMI parameters. 
The concomitant BT pathology partially influences the parameters of lipid blood spectrum. HDL was equally decreased in 
all patients with NASH at CNC and CCC relative to patients with concomitant PCES and HDL level within physiological norm. At 
NASH in combination with obesity at increase of BMI the DL phenomena more often appear in patients. There are separated two 
main phenotypes of dyslipidemias: IIa and IIb. 
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1. Introduction
Liver plays an important role for development of lipid metabolism with formation of dyslip-
idemia (DL). According to the literature data, DL (hypertriglyceridemia, hypercholesterolemia or 
their combination) are often observed at fatty disease of liver – in 20–81 % of cases [1]. Today the 
term “dyslipidemia” is connected with diverse changes of lipid spectrum in blood plasma – rise, 
lowering or even complete absence of separate fractions, appearance of unusual or pathological 
phenotypes [2]. DL is a proved risk of development of NAFDL [3], obesity [4] and cardiovascular 
pathology [5–7].
The changes of lipid metabolism begin at the level of hepatocyte [8]. Chronic diffuse dis-
ease of the liver (CDDL) and namely non-alcoholic fatty disease of the liver (NAFDL) is a specific 
model of disorder of many mechanisms of lipid metabolism regulation. According to the literature 
data, the disorders of lipid metabolism are based on disorders of the functional state of liver [9]. 
It is typical, that in patients with NAFDL at hypertriglyceridemia non-alcoholic steatohepatitis 
(NASH) develops more often that at hypercholesterolemia [1].
Analysis of literature demonstrates that at excessive body mass (EBM) or obesity is usually 
observed the certain degree of disorder of lipid, carbohydrate and other metabolisms [10]. Obesity 
is associated with DL, including the intense hypertriglyceridemia, increase of the content of lipo-
proteins of very low density, decrease of formation of lipoproteins of the high density (HDL) [11].
At the modern stage the data about disorders of lipid exchange, collected in literature, can 
form hypothesis, according to which, as a result of human evolution as biological specie was creat-
ed the specific type of lipid metabolism, at which even the middle (normal) level of cholesterol (CS) 
is potentially dangerous in the aspect of DL development [3] and, as a consequence, NAFDH [2], 
cholesterosis of gall bladder, cholelithiasis or adipogenous pancreatitis [12]. It is possible, that the 
special “tension” of the human lipid metabolism can be the retribution for the way of life: features 
of nutrition, insufficient physical and intense intellectual activity, non-season hormonal activity [3]. 
The other important proposition is that the hypercholesterolemia it is not a single factor of disorder 
of lipid exchange and the risk of NAFDL and obesity development [2].
According to our researchers, the lipids of the blood serum, measured in the different pe-
riods of development of hepatobiliary pathology can be the weak reflection of the true DL in the 
critical time of gallstones creation [1]. The proof of this statement is the following facts: after 
cholecystectomy the decrease of lipids of blood serum is registered and at exacerbation of chronic 
calculous cholecystitis, especially, at appearance and increase of concrements the lipids level in 
blood reliably raises [12].
Thus, for adequate analysis of disorders of lipid metabolism at NAFDL it is important to 
evaluate not only the level of general cholesterol (GCS) in blood but also the level of lipoproteins of 
the low density (LDL), HDL, general lipids (GL) and also obligatory the level of triglycerides (TG). 
2. Aim of the work
To study the main indices of lipid spectrum of blood, which changes lead to the DL for-
mation, depending on body mass index (BMI) and concomitant pathology of biliary tract (BT) in 
patients with NASH in combination with obesity. 
3. Materials and methods
There were examined 100 patients with NASH in combination with obesity and BT pathology, 
who were on stationary treatment in clinic of SI “Institute of gastroenterology, NAMS of Ukraine”, 
in which were detected the sigs of hepatic steatosis during sonographic or morphological study of bioptat 
of the liver. Among patients were 40 men and 60 women. The mean age of patients – (54,68±1,15) years 
old. The control group included 20 practically healthy persons (PHP). All patients signed the informed 
consent to participation in the research. 
Diagnosis of NASH and BT pathology was set according to standardized protocols of di-
agnostics and treatment of diseases of digestive organs in correspondence with order of MHP of 
Ukraine № 271 of 13.06.2005 year and № 826 of 06.08.2014 [13, 14], ICD-10, on the base of the 
data of anamnesis, clinical and instrumental (ultrasound of organs of abdominal cavity, intraop-
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erational puncture biopsy of the liver) examination, with obligatory taking into account of data of 
conventional biochemical indices and on the base of increase of the hepatic enzymes level. The in-
tensity of NASH was evaluated by the level of alanine aminotransferase (ALT): minimal at increase 
of ALT up to two norms, moderate from 3 to 5 norms, high – more than five norms. 
Patients involved into research do not overused alcohol (consumption <50 g of ethanol/week 
for men, <30 g of ethanol/week for women during last year). In examined persons were not revealed 
serum markers of viral hepatitis В and С, autoimmune and hereditary disease of liver. 
All patients underwent wide anthropometric examination: were weighted fasting, their height 
was measured, the volume of waist (VW) and hips (VH) were determined. The index of VW/VH ra-
tio was used for determination of character of fat distribution in organism. Obesity was considered 
as abdominal one, if in women the value of VW/VH >0,88, in men >0,90 [15]. BMI was determined 
by the Quetelet formula. Depending of the degree of BMI increase all patients with NASH and obe-
sity were divided into three groups: 1 group – with BМI 25–29,9 kg/m2 – EBM; 2 group – with 
BMI 30–34,9 kg/m2 – obesity of I degree; 3 group – with BMI 35–39,9 kg/m2 – obesity of ІІ degree. All 
examined patients had concomitant pathology from BT side. Depending on BT pathology all patients 
were also divided into 3 groups: NASH with chronic non-calculous cholecystitis (CNC); NASH with 
chronic calculous cholecystitis (CCC); NASH in patients after laparoscopic cholecystectomy (LCE) 
with concomitant postcholecystectomical syndrome (PCES). For characteristic of lipid exchange were 
determined the general cholesterol (GCS), general lipids (GL), triglycerides (TG), lipoproteins of the 
low density (LDL), lipoproteins of the high density (HDL). The GL and TG content in blood was stud-
ied using the sets of “Lachema” biotest, GCS content – by Ilk method, LDL and HDL – according to 
Burstein and Samay [5].
DL phenotype was determined by D.S. Fredrickson classification with modern additions. DL 
criteria in examined persons were the levels of GCS– 5,0 mmol/l, ТG – 1,7 mmol/l, HDL – 1,0 mmol/l 
in men and 1,2 mmol/l in women and LDL 52,5 – units [8].
For diagnostics of hepatic steatosis was used the ultrasound method [3], that give a possibility 
not only to assess the state of liver but also reveal the deviation of BT, hepatic vessels and pancreas 
with the help of sonographic system of the linear scanning in the real time “Sonoscope-30” made by 
Krancbühler. The study was carried out fasting. Analysis of structural changes of digestive organs 
included assessment of sizes, outlines, acoustic structure and echogenisity of liver and pancreas, state 
of biliary system by the conventional method [4].
For verification of diagnosis 22 patients underwent intraoperational biopsy of liver with 
the further study of its histostructure. For histological examination the cuts were colored with 
hematoxylin and eosin by the method of Mallory-Slinchenko [7]. The state of histostructure of 
liver was assessed half-quantitatively in the system of stages (0 – absent, 1 – insignificant, 3–5 %, 
2 – moderate, 3 – intense 60–100 %), the type of cholestasis, degree of chronic inflammation de-
gree of protein, fatty and carbohydrate dystrophy. Histological preparations were studied using the 
photic microscope „LIUMAM-I2”.
For statistical analysis of data was used STATISTICA 6.1 license program. Qualitative indi-
ces, given as a mean value and standard error of mean (М±m). For comparison of mean indices in all 
subgroups was used the Student’s criterion and ANOVA univariate disperse analysis; for relative in-
dices – Pirson’s Хі-square criterion (c2). For assessment of interconnection between signs correlative 
analysis with calculation of coefficients of Spearman’s range correlation was realized (rs).
4. Results
Analysis of lipid changes in patients with NASH (Table 1) demonstrated the reliable in-
crease of GCS with parallel increase of TG, GL, LDL, fixed at the growth of BMI, relative to 
PHP (from р<0,05 to р<0,001) and patients of other groups р<0,05). GCS in patients with NASH 
was 8,69±0,55 in 3 group аnd 7,77±0,36 mmol/l in 2 group, with increase by 35,6 % and 21,2 % 
respectively relative to the patients of 1 group (6,41±0,49 mmol/l; р<0,05) and with increase in 1,7 
and 1,5 times as to PHP (р<0,001 at all comparisons). The maximal values of TG were also detect-
ed in 3 and 2 groups of observation (2,60±0,16 mmol/l and 2,47±0,17 mmol/l, respectively) with 
increase by 38,3 % and 31,4 % comparing with 1 group with TG level 1,88±0,15 mmol/l (р<0,05) 
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and with decrease in 2,3 and 2,2 times as to PHP (р<0,001 at all comparisons). The level of GL 
maximally changed in patients of 3 group (9,54±0,31 g/l), exceeding the respective values in PHP 
in 1,8 times (р<0,001), in patients of 1 group (7,31±0,33 g/l) by 30,5 % (р<0,001), indices in 2 group 
(8,41±0,26 g/l) – by 13,4 % (р<0,01). 
Table 1
Comparative characteristic of indices of lipid metabolism in patients with non-alcoholic steatohepatitis in 
combination with obesity and biliary tract pathology depending on BMI (M±m)
Index PHP, n=20
NASH, n=100
1 group, 
BMI (25–29,9 kg/m2), 
n=40
2 group, 
BMI (30–34,9 kg/m2), 
n=37
3 group, 
BMI (35–39,9 kg/m2), 
n=23
рF between groups 
GCS, mmol/l 5,23±0,17 6,41±0,49* 7,77±0,36**# 8,69±0,55**# 0,005
TG, mmol/l 1,14±0,09 1,88±0,15** 2,47±0,17**# 2,60±0,16**# 0,005
GL, g/l 5,18±0,30 7,31±0,33** 8,41±0,26**# 9,54±0,31**#² <0,001
LDL, unit 38,5±2,2 63,6±5,9** 83,6±7,1**# 96,2±10,0**# 0,010
HDL, mmol/l 1,62±0,05 1,66±0,14 1,15±0,07**# 1,05±0,08**# 0,001
Note: * – p<0,05; ** – p<0,001 comparing with PHP group; # – p<0,05 comparing with correspondent group of pa-
tients with BMI 25–29,9 kg/m2; ² – p<0,05 comparing with correspondent group of patients with BMI 30–34,9 kg/m2; 
рF – level of significances of differences of indices between groups with different BMI in whole by ANOVA univariate 
disрerse analysis
There was a significant increase of fractions of atherogenic LDL that was also fixed in 3 
and 2 groups and reached maximal values (96,2±10,0 units and 83,6±7,1 units respectively) with 
increase in 1,5 and 1,3 times comparing with patients of 1 group and LDL level – 63,6±5,9 units 
(р<0,05 at all comparisons) and with increase in 2,5 and 2,2 times as to PHP (р<0,001 at all com-
parisons). In patients with NASH, who had BMI 30–34,9 kg/m2 and 35–39,9 kg/m2, concentration of 
antiatherogenic HDL fraction in blood serum was lower (1,15±0,07 mmol/l and 1,05±0,08 mmol/l, 
respectively) comparing with BMI 25–29,9 kg/m2 (р<0,01) and PHP (р<0,001). At that HDL level 
in patients with BMI 25–29,9 kg/m2 did not differ from PHP values (р>0,05).
The direct dependence of indices of lipid profile from BMI is demonstrated by the results of 
correlative analysis: BMI increase led to the growth of the levels of GCS (rs=0,454, р<0,001), TG in 
plasma (rs=0,417, р<0,001), LDL (rs=0,393, р<0,001), GL (rs=0,465, р<0,001) and reliable lowering 
of HDL (rs=–0,356, р<0,001).
Analysis of distribution of changes of indices of lipid metabolism comparing with norm 
(Fig. 1) demonstrated that GCS level was increased in 35 (94,6 %) patients of 2 group, in all patients 
of 3 group (n=23–100 %) and only in 25 (62,5 %) patients from 1 group (р<0,01), that shows an ex-
pressed dependence of lipid blood spectrum parameters from BMI indices. Analogous reliable data 
were observed also relative to the indices of TG, GL and LDL. Maximal number of increased data of 
TG was in 2 group – 34 (91,9 %) and 3 group – 23 (100 %) against 24 (60 %) cases in 1 group (р<0,01).
GL increase was typical for 22 (95,7 %) patients from 3 group, for 25 (67,5 %) ones from 
2 group that reliably (р<0,01) increased the correspondent indices in patients of 1 group (n=13–32,5 %). 
GL value within physiological norm was observed only in 1 (4,3 %) patient from 3 group relative to 
12 (32,4 %) from 2 group, р<0,01 and 27 (67,5 %) from 1 group, (р<0,001). 
LDL level was increased in all patients 23 (100 %) from 3 group, in 31 (83,8 %) from 2 group 
comparing with only 15 (37,5 %) patients from 1 group (р<0,01). LDL normal values were observed 
in 2 group only in 5 (13,5 %) against 19 (47,5 %) from 1 group (р<0,01). The opposite tendency of 
changes was established at analysis of index of HDL content in the blood of patients with NASH in 
all groups of comparison. Especially, there was registered the reliable decrease of HDL content in 
most patients from 3 group – in 15 (65,2 %) relative to 16 (43,2 %) patients from 2 group and only 
to 5 (12,5 %) from 1 group (р<0,01). 
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Fig. 1. Distribution of changes of the lipid metabolism parameters comparing with norm in 
patients with non-alcoholic steatohepatitis in combination with obesity depending of BMI:  
* – p<0,05; ** – p<0,01 comparing with correspondent group of patients with BMI 25–29,9 kg/m2;  
# – p<0,05 comparing with correspondent group of patients with BMI 30–34,9 kg/m2
At detail consideration of lipid profile indices in patients with NASH in combination with 
obesity depending on concomitant BT pathology (Table 2) analogical tendencies were revealed and 
they were expressed by all indices of lipid spectrum. Thus, GCS content – 7,18±0,38 mmol/l ex-
ceeded PHP value by 37,3 % in patients with concomitant CNC, by 49,7 % in patients with CCC and 
by 40,7 % at PCES (р<0,001 at all comparisons). TG indices also were almost equally increased in 
all groups of observation with maximal increase in 2,1 times as to PHP in patients with PCES, and 
in 1,9 times in patients with concomitant CNC and CCC (р<0,001 at all comparisons). 
Table 2
Comparative characteristic of indices of lipid metabolism in patients with non-alcoholic steatohepatitis in 
combination with obesity depending on concomitant pathology of biliary tract (М±m)
Index PHP, n=20
NASH
With CNC, n=35 With CCC, n=30 With PCES, n=35 рF between groups
GCS, mmol/l 5,23±0,17 7,18±0,38* 7,83±0,55* 7,36±0,54* 0,639
TG, mmol/l 1,14±0,09 2,15±0,19* 2,21±0,16* 2,42±0,16* 0,486
GL, g/l 5,18±0,30 8,09±0,29* 8,04±0,43* 8,53±0,32* 0,540
LDL, unit 38,5±2,2 80,2±7,3* 83,6±9,6* 72,4±6,0* 0,565
HDL, mmol/l 1,62±0,05 1,16±0,08*# 1,19±0,10*# 1,63±0,16 0,009
Note * – p<0,001 comparing with PHP group; # – p<0,05 comparing with correspondent group of patients 
with PCES; рF – level of significance of difference of indices between groups with NASH in whole by ANOVA uni-
variate disperse analysis
GL content was also increased in all patients with NASH, in 1,6 times at CNC and CCC and 
in 1,7 times in patients with concomitant PCES (р<0,001 at all comparisons). LDL values were in-
creased in 1,9 times at concomitant PCES and in 2,1 and 2,2 times respectively in patients with con-
comitant CNC and CCC (р<0,001 at all comparisons). HDL was equally decreased in groups with 
concomitant CNC and CCC in 1,4 times (р<0,001) and did not differ from PHP indices in patients 
with concomitant PECS that indicates to the less inflammatory activity in BT after LCE. This point 
of view is proved also by the less intergroup increase of LDL in patients with concomitant PCES. 
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Revelation of deviations of the lipid metabolism indices depending on the limit of physio-
logical norm in patients with NASH in combination with obesity taking into account BT pathology 
is presented on the Fig. 2. According to the data of Fig. 2, the raise of FCS, TG, GL and LDL was 
observed with equal frequency in all groups of observation. The reliably significant changes of 
HDL level at the expense of their decrease were typical for patients with concomitant PCES and 
were observed in 8 (22,9 %) against 17 (48,6 %) in patients with concomitant CNC (р<0,05). 
Fig. 2. Distribution of changes of lipid metabolism indices comparing with norm in patients with 
non-alcoholic steatohepatitis in combination with obesity depending on concomitant pathology of 
biliary tract: * – p<0,05 comparing with correspondent group of patients with CNC
Analysis of frequency of revelation of the main dyslipidemia phenotypes among patients 
with NASH in combination with obesity and BT pathology depending on BMI is presented in the 
Table 3 and Fig. 3.
Table 3
Frequency of revelation of the main dyslipidemia phenotypes among patients with non-alcoholic steatohepatitis 
in combination with obesity and pathology of biliary tract depending on BMI 
Groups
DL presence/absence 
Absence of DL DL phenotype
ІІа ІІb
NASH, n=100
BMI-1.2  
(25–29,9 kg/m2), n=40 25 (62,5 %) 4 (10,0 %) 11 (27,5 %)
BMI-2.2 
(30–34,9 kg/m2), n=37 6 (16,2 %)* 5 (13,5 %) 26 (70,3 %)*
BMI-3.2 
(35–39,9 kg/m2), n=23 –* 5 (21,7 %) 18 (78,3 %)*
р
χ2
 between groups <0,001 0,431 <0,001
Note: * – p<0,001 comparing with correspondent group of patients with BMI 25–29,9 kg/m
2; р
χ2 
– level of significance of differ-
ences between groups with different BMI in whole by χ2 criterion
According to the table data, at NASH reliable changes were detected relative to the patients with 
BMI 25–29,9 kg/m2 (р<0,001). Thus, IIb phenotype was observed in 26 (70,3 %) patients with BMI 
30–34,9 kg/m2 and in 18 (78,3 %) with BMI 35–39,9 kg/m2 against 11 (27,5 %) at BMI 25–29,9 kg/m2 
(р<0,001). The absence of DL was fixed only in 6 (16,2 %) patients with BMI 30–34,9 kg/m2 and 
was not observed at all at BMI 35–39,9 kg/m2 relative to patients with BMI 25–29,9 kg/m2 – in 25 
(62,5 %) (р<0,001).
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Fig. 3. Distribution of dyslipidemia types in patients with NASH in combination with obesity  
and BT pathology
5. Discussion
In patients with NASH in combination with obesity and BT pathology the disorders of lipid 
metabolism play one of the main roles in the formation of metabolic status. There were established 
the features of changes of the lipid blood spectrum in this category of patients that are manifested 
in variability of disorders from hypercholesterolemia to hypertriglyceridemia on the background of 
increase of LDL and decrease of HDL. The received data of comparative evaluation of lipid param-
eters of patients with NASH in combination with obesity and BT pathology testify that TG play an 
important role in formation of lipoproteins, increase of GL and LDL content in patients with NASH. 
The decrease of intensity of reverse transport of GCS from tissues to liver as a result of 
insufficient synthesis of HDL and essential level of hypercholesterolemia in LDL content and hy-
pertriglyceridemia create conditions not only for development and progression of NAFDL but also 
for the vascular disorders, especially, atherosclerotic injury of the main vessels and the ones of 
liver and create conditions for formation of the vascular component of NAFDL pathogenesis and 
its progression. 
The received data testify that progression of intensity of lipid disorders in patients with 
NASH in combination with obesity and BT pathology depend on increase of BMI parameters. 
Analysis of lipid changes in patients with NASH demonstrated the reliable increase of GCS with 
parallel raise of TG, GL, LDL, fixed at growth of BMI relative to PHP (from р<0,05 to р<0,001) 
and patients of the other groups (р<0,05). The highest indices of GCS, TG, GL, LDL were in pa-
tients with NASH and obesity of I degree (р<0,001) and obesity of II degree (р<0,001), and the 
least heightened parameters of the lipid blood spectrum, relative to PHP, at BMI (р<0,05; р<0,001). 
Analogous changes but with decrease of HDL were also fixed at obesity of I and II degree in pa-
tients of groups of NASH relative to PHP (р<0,05). Along with it, at EBM HDL content did not 
differ from PHP values (р>0,05). It is possible to assume that BMI changes on the background of 
its growth act as independent additional factor of progression of NASH in combination with obesity 
and also favor the development and progression of other metabolic disorders. 
On the background of received data, depending on concomitant BT pathology is obvious 
that the lipid metabolism disorders were observed in all groups of patients with NASH in combi-
nation with obesity, were characterized with hypertriglyceridemia and disorder of metabolism and 
transport of CS, that were more intense in patients with NASH and concomitant CNC and CCC at 
the lowered HDL level. The presence of concomitant pathology from BT side partially influenced 
the indices of lipid blood spectrum. Thus, the low level of HDL in patients with NASH in combi-
nation with obesity and concomitant CNC anc CCC can be explained by the intense inflammatory 
processes in biliary tract, attended with disorders of indices of lipid profile with decrease of HDL 
and increase of CS, TG, GL and LDL. 
The received data testify that at NASH with increased BMI the DL phenomena take place 
more and more often. There were separated two main phenotypes of dyslipidemia: IIa та IIb, which 
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comparing with nosology and stage of disease of patients allowed consider them as the main phe-
notypes, typical for the studied comorbid pathology. The second phenotype of dyslipidemia is 
manifested as a complex of biological defects of lipid metabolism as moderate hyperlipidemia and 
is typical for patients with NASH. 
In further works it is planned to study the lipid-phospholipid disorders, depending on BMI 
and reveal their influence on progression of the main disease in patients with comorbid course of 
non-alcoholic fatty disease of liver and obesity on the background of concomitant pathology of 
biliary tract. 
6. Conclusions
1. Progression of intensity of lipid disorders in patients with NASH in combination with obe-
sity and BT pathology depends on increase of BMI parameters. The most indices of GCS, TG, GL, 
LDL were in patients with NASH at obesity of I degree (р<0,001) and obesity of II degree (р<0,001), 
and the lowest parameters of lipid blood spectrum, relative to PHP, at EBM (р<0,05, р<0,001).
2. Concomitant pathology from BT side partially influenced the indices of lipid blood spec-
trum. Thus, HDL were equally decreased in patients with NASH at concomitant CNC and CCC 
relative to the norm (р<0,001) and HDL level within physiological norm in patients with concom-
itant PCES (р>0,05).
3. At NASH in combination with obesity with BMI increase the DL phenomena appear in 
patients more often. There were two main phenotypes of dyslipidemia: IIa та IIb. Is was established, 
that IIb phenotype of dyslipidemia was most often observed in patients with BMI 30–34,9 kg/m2 
and 35–39,9 kg/m2 as to patients with BMI 25–29,9 kg/m2 (р<0,001).
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